Although a number of research have been realized in the aim of decreasing t
he use of platelet concentrates, these blood products remain absolutely nec
essary for patients with therapeutic aplasia and for some surgical patients
.
After the description of the main rules of platelet transfusion procedures,
we will discuss some controversial issues: threshold value for platelet tr
ansfusion, platelet doses, place of curative and prophylactic strategies, r
efractoriness to platelet transfusion, HLA alloimmunization. Then we will f
ocus our review on the future alternatives for platelet transfusion.